• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 119
  • 58
  • 31
  • 10
  • 9
  • 4
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • Tagged with
  • 302
  • 126
  • 80
  • 74
  • 61
  • 55
  • 42
  • 27
  • 25
  • 24
  • 24
  • 23
  • 22
  • 21
  • 20
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
81

Imunologický profil u pacientů s roztroušenou sklerózou / Immunological profile of patients with multiple sclerosis

Šubjak, David January 2012 (has links)
Immunological profile of multiple sclerosis patients Abstrakt Multiple sclerosis is an autoimmune neurodegenerative disease affecting predominantly the white matter of the CNS and the spinal cord. The mechanism of disease progression is not yet fully understood. In this study we focused on a comparison of selected immunological markers between patients with multiple sclerosis who were naïve newly diagnosed, subsequently treated with Avonex (IFNβ1a) and healthy donors. The T cells (particulary cytotoxic CD8+ T cells) are the major population involved in pathogenesis of MS causing the demyelization of axons. Subpopulation of CD161+ Th cells has a potential to be very important in this process. We focused on the role of NK cells phenotype and function in autoimmune response of patients and their changes during the therapeutic intervention. Using flow cytometry we analyzed the distribution of NK, NKT, T cells and monocytes with special regard to the expression of CD161 and NKG2D molecules on their surface. We observed increase counts of CD161+ cells in subpopulations NK CD56bright , NK CD56dim , Th, Tc CD8bright , Tc CD8dim and decrease counts of NKG2D+ cells in subpopulations NK CD56bright , NK CD56dim , NKT, Th, Tc CD8bright , Tc CD8dim and monocytes. The decreased cytotoxic activity of NK cells in naïve MS...
82

Caracterização bioquímica, estrutural e funcional de uma L-aminoácido oxidase isolada de peçonha de Lachesis muta (Serpentes, Viperidae) / Purification, biochemistry and functional characterization of a new L-amino acid oxidase from Lachesis muta venom.

Silva, Cristiane Bregge da 31 October 2011 (has links)
As peçonhas de serpentes contêm uma mistura complexa de substâncias farmacologicamente ativas, como metaloproteases, fosfolipases A2, serino-proteases, L-aminoácido oxidase (LAAO), além de outros importantes compostos sem ação enzimática. LAAOs são flavoproteínas que catalisam a desaminação oxidativa de L-aminoácidos e produzem o -cetoácido correspondente, com a concomitante liberação de amônia e peróxido de hidrogênio. A peçonha de Lachesis muta (L. muta) contém L-aminoácido oxidase, a qual pode contribuir com o envenenamento. Portanto, o objetivo deste trabalho é a purificação da L-amino acido oxidase de peçonha de Lachesis muta (LmLAAO) e a sua caracterização bioquímica, estrutural e funcional. Para isso, foram desenvolvidos dois protocolos distintos de purificação, os quais forneceram LmLAAO com grande pureza. No primeiro protocolo, 20 mg de peçonha bruta de L. muta foram submetidos a uma gel filtração em Sephacryl S100®. Das dez frações obtidas, a primeira fração apresentou atividade L-aminoácido oxidase e foi submetida a mais um passo cromatográfico em Mono Q®. A homogeneidade da fração com atividade L-aminoácido oxidase após a troca iônica foi comprovada por presença de banda única com 60,2 kDa em SDS-PAGE. O segundo protocolo de purificação foi uma sequência de três passos cromatográficos, na qual 200 mg de peçonha bruta de L. muta foram submetidos a gel filtração em Sephacryl S200®, seguido por interação hidrofóbica em Phenyl Sepharose® e Affi- gel Blue Gel®. Da mesma forma, a pureza da enzima obtida depois desses passos cromatográficos foi comprovada por presença de banda única com 64 kDa em SDS-PAGE. Em ambos os protocolos de purificação, LmLAAO manteve sua atividade enzimática. A massa molar de LmLAAO foi determinada por espectrometria de massas (MALDI-TOF) e apresentou valor de 60,85 kDa. Além disso, foi determinado o valor do ponto isoelétrico da LmLAAO como 5,1. A LmLAAO mostrou preferência catalítica por aminoácidos hidrofóbicos (L-Metionina L-Leucina e L-Fenilalanina) e apresentou perda de atividade catalítica quando submetida à altos valores de pH ou de temperatura. Os parâmetros cinéticos foram determinados e a constante de Michaelis-Menten para o substrato L-Leucina foi de 0,9737 mmol/L e a velocidade máxima de reação foi de 0,06345 mol peróxido de hidrogênio/min. A sequência N-terminal dos 40 primeiros resíduos da LmLAAO purificada foi determinada por degração de Edman e a sua estrutura primária completa foi deduzida da sequência do cDNA obtido da glândula de peçonha. Verificou-se uma grande identidade entre as sequências em aminoácidos da LAAO de L. muta e as de outros viperídeos. A estrutura da LmLAAO foi resolvida por substituição molecular usando as coordenadas atômicas da LAAO de Agkistrodon halys pallas (PDB 1REO). As atividades farmacológicas da LmLAAO foram determinadas in vivo e in vitro. A injeção da enzima (10 µg) não induziu edema de pata em camundongos, nem hemorragia (50 µg) e nem toxicidade sistêmica (100 µg). No entanto, provocou uma leve mionecrose (100 µg) e edema em músculo quadríceps de camundongo, aumentando a creatina quinase plasmática. In vitro, foram testadas as atividades citotóxicas da LmLAAO em células de carcinoma. Os dados obtidos mostram IC50 de 22,70 µg/mL, para linhagem AGS (carcinoma de estômago), e IC50 de 1,41 µg/mL linhagem MCF-7 (carcinoma de mama). Para a atividade antiparasitária, foi determinada uma IC50 de 2,22 µg/mL para a forma promastigota de Leishmania brasiliensis. No entanto, a LmLAAO (32 µg/mL) não apresentou toxicidade relevante para a forma tripomastigota de Tripanosoma cruzi. Concluindo, este trabalho descreve o isolamento e a caracterização estrutural e funtional de uma nova LAAO da peçonha de L. muta. A enzima mostrou efeitos antitumorais e leishmanicida, sem toxicidade sistêmica relevante, mas apresentou significativa ação edematogênica e miotóxica local. Este estudo é relevante não apenas por contribuir para uma melhor compreensão do papel da LAAO no envenenamento, mas também por demonstrar seu potencial biotecnológico como agente terapêutico. / Snake venoms comprise a complex mixture of pharmacologically active substances, such as metalloproteases, phospholipase A2, serine proteases and L-amino acid oxidases (LAAOs) other compounds showing no enzymatic activity. LAAOs are flavoproteins catalyzing the oxidative deamination of L-amino acids to produce the corresponding -keto acid with the concomitant release of ammonia and hydrogen peroxide. Lachesis muta (L. muta) venom contains L-amino acid oxidase which may contribute to the envenomation. The aim of this study is the purification of an L-amino acid oxidase from Lachesis muta venom (LmLAAO) and its structural and functional characterization. For that, two purification protocols were performed and both provided highly pure LmLAAO. In the first protocol, 20 mg of crude venom of L. muta were submitted to a gel filtration on Sephacryl S100® and yielded ten fractions, whose were tested for L-amino acid oxidase activity. The first fraction showed L-amino acid oxidase activity and it was submitted to a further chromatographic step on Mono Q®. The homogeneity of the fraction showing L-amino acid oxidase activity after ion exchange was confirmed by the presence of a single band corresponding to 60.2 kDa by SDS-PAGE. The second purification protocol was a sequence of three chromatographic steps, where 200 mg of crude L. muta venom were submitted to gel filtration on Sephacryl S200, followed by hydrophobic interaction on Phenyl Sepharose® and Affi-gel-Blue Gel. For the second protocol, the purity of LmLAAO was confirmed by the presence of a single band with 64 kDa as determined by SDS-PAGE. In both purification protocols LmLAAO kept its enzymatic activity. The molar mass of LmLAAO was determined by mass spectrometry (MALDI-TOF) and showed a value of 60.85 kDa. Moreover, the isoelectric point was 5.1. In addition, LmLAAO showed a catalytic preference for hydrophobic amino acids (L-methionine, L-leucina and L-phenylalanine) and lost its catalytic activity when subjected to high pH or temperature. The kinetic parameters for LAAO were determined and the Michaelis-Menten constant for the substrate L-leucine was 0.9737 mmol/L, and the maximum reaction velocity was 0.06345µmol hydrogen peroxide/min. Furthermore, the sequence of the first forty residues was determined by Edman degradation and the complete sequence of LmLAAO was resolved by cloning cDNA obtained from the venom glands. The amino acid sequence of LmLAAO showed a great identity with sequences of LAAOs from other viper snakes. The LmLAAO structure was solved by molecular replacement using the the atomic coordinates of the LAAO from Agkistrodon halys pallas (PDB 1REO). In addiction, LmLAAO pharmacological activities were determined in vivo and in vitro. Thus, LmLAAO (10 µg) did not induce paw edema in mice, neither hemorrhage (50 µg) nor systemic toxicity (100 µg). However, it caused a mild myonecrosis (100 µg) and edema in the quadriceps muscles of mice, increasing plasma creatine kinase. In vitro activities of LmLAAO in carcinoma cells was assayed. The IC50 of LmLAAO on AGS cell line (stomach cancer) was 22.70 µg / mL, and the IC50 of LmLAAO on MCF-7 cell line (breast carcinoma) was 1.41 µg/mL. Moreover, antiparasitic activity of LmLAAO was determined on promastigote of Leishmania brasiliensis and an IC50 of 2.22 µg/mL was found, whereas on trypomastigote form Trypanosoma cruzi LmLAAO showed no toxicity at doses of 32 µg/mL. In conclusion, this work reports the isolation and the structural and funtional characterization of a new LAAO from L. muta snake venom. The enzyme showed antitumoral and leishmanicidal effects, without relevant systemic toxicity, but presented a significant local edema inducing and myotoxic action. This study is relevant not only for contributing to a better understanding of LAAO role in envenomation, but also for demonstrating its biotechnological potential as a therapeutic agent.
83

Avaliação dos efeitos do fipronil (ingrediente ativo do FRONTLINE®) nos ovários de carrapatos Rhipicephalus sanguineus (Latreille, 1806) (Acari: Ixodidae) e no sangue periférico de roedores

Oliveira, Patrícia Rosa de [UNESP] 31 August 2010 (has links) (PDF)
Made available in DSpace on 2014-06-11T19:30:56Z (GMT). No. of bitstreams: 0 Previous issue date: 2010-08-31Bitstream added on 2014-06-13T18:41:13Z : No. of bitstreams: 1 oliveira_pr_dr_rcla.pdf: 1096326 bytes, checksum: a2a1be84ec8b09cfcf7ab3110daa8ce4 (MD5) / O presente estudo avaliou os efeitos do fipronil em fêmeas semi-ingurgitadas de carrapatos Rhipicephalus sanguineus por meio do desenvolvimento de protocolo adequado de bioensaio in vitro (AIT), monitorado diariamente, com determinação da CL50 (concentração 50% letal) e intervalo de confiança a 95%, g (95): CL50 = 9.647 ppm (4.711 a 13.470), bem como analisou os efeitos histológicos e ultra estruturais deste produto nos ovários desses indivíduos, demonstrando quais são os mecanismos de defesa utilizados pelas células germinativas para eliminar o composto químico do sistema. Para o estudo morfológico, os carrapatos foram divididos em quatro grupos, onde o grupo I foi utilizado como controle e os grupos II, III e IV, foram submetidos às concentrações de 1, de 5 e de 10 ppm (CL50) de fipronil, respectivamente. As alterações variaram desde a presença de poucos e pequenos vacúolos até a interrupção da vitelogênese e morte celular. A concentração de 10 ppm de fipronil foi a que mais afetou o desenvolvimento dos ovócitos. Mecanismos de defesa celular como o aumento da quantidade e novo arranjo citoplasmático de elementos do citoesqueleto, bem como a grande quantidade de vacúolos digestivos e de figuras mielínicas foram observados. Simulando a ação do fipronil nos hospedeiros de carrapatos expostos aos acaricidas que tenham esse princípio ativo em sua composição, o presente estudo avaliou também o potencial citotóxico (danos causados nas células do fígado), genotóxico e mutagênico do fipronil utilizando camundongos submetidos a diferentes doses da droga. Os camundongos foram divididos em quatro grupos: grupo controle e grupos I, II e III, que foram expostos às doses de 15mg/Kg, 25 mg/Kg e 50 mg/Kg (DL50) de fipronil, respectivamente. Em seguida, o fígado dos indivíduos foi retirado, seccionado e analisado por meio de técnicas histológicas e histoquímicas... / The present study evaluated the effects of fipronil on semi-engorged females of the tick Rhipicephalus sanguineus. A protocol for an in vitro bioassay (AIT) was developed, and the LC50 (lethal concentration 50%) and 95% confidence interval were determined: LC50 = 9.647 ppm (4.711 to 13.470). Histological and ultrastructural alterations in ovaries were also examined to describe the defense mechanisms of germ cells to eliminate the chemical compound from the system. For the morphological analysis, ticks were divided into four groups. Group I was used as the control group and groups II, III,and IV were exposed to concentrations of 1, 5, and 10 ppm (LC50) of fipronil, respectively. Alterations varied from the presence of few and small vacuoles to the interruption of vitellogenesis and cell death. The concentration of 10 ppm of fipronil had the strongest effect on oocyte development. Defense mechanisms of cells were observed such as increase in the amount and changes in the arrangement in the cytoskeleton elements in the cytoplasm, amount of digestive vacuoles and myelin figures. Simulating the action of fipronil in tick hosts exposed to fipronil, the present study also assessed the cytotoxic (damage caused in liver cells), genotoxic, and mutagenic potential of fipronil in mice treated with different doses. Mice were divided into four groups: control group and groups I, II, and III, which were exposed to doses of 15mg/Kg, 25 mg/Kg, and 50 mg/Kg (LD50) de fipronil, respectively. The liver of mice were dissected, sectioned, and analyzed with histological and histochemical techniques. Changes varied from proliferation of Kupffer cells, hypertrophy of hepatocytes, accumulation and distribution of proteins, polysaccharides, lipids, and presence of vacuoles in the cytoplasm of hepatocytes, as well as the obstruction of blood vessels, characterizing mainly a) autophagic processes, b) steatosis... (Complete abstract click electronic access below)
84

Synthèse totale de la laxaphycine B : un lipopeptide cyclique d’origine marine : extension à d’autres peptides apparentés. / Total synthesis of laxphycine B : a marine cyclic lipopeptide : extension to analogues' peptides.

Boyaud, France 16 October 2013 (has links)
Le milieu marin représente une source d'inspiration pour les chimistes, grâce à l'incroyable diversité structurale des composés isolés des organismes et micro-organismes marins. Parmi eux, la laxaphycine B, un lipopeptide cyclique isolée de la cyanobactérie Anabaena torulosa est comme la plupart des peptides marins produit selon une voie de biosynthèse non ribosomale « NRPS /PKS » et présente une forte activité cytotoxique sur différentes lignées cellulaires cancéreuses. Une des problématiques de ce lipopeptide est l'absence d'information sur son mécanisme d'action. Afin d'identifier des cibles potentielles, mais surtout d'entreprendre des études des relations structure-activités, la confirmation de sa structure est nécessaire. C'est dans cette optique que nous avons entrepris la synthèse de la laxaphycine B en synthèse peptidique en phase solide (SPPS). Dans un premier temps, nous avons entrepris la synthèse des quatre aminoacides non ribosomaux. Dans un second temps, nos efforts se sont concentrés sur le développement d'une stratégie de synthèse pour l'obtention de ce lipopeptide. En dernier lieu, nous avons étudié la structure secondaire possible de la laxaphycine B, afin d'apporter une explication sur son mécanisme d'action. / Marine environment is a source of inspiration for chemists, thanks to the incredible structural diversity isolated from marine organisms and microorganism's compounds. Among them, laxaphycine B, a cyclic lipopeptide isolated from Anabena torulosa cyanobacteria, as like most marine peptides produced by a non-ribosomal biosynthesis pathway "NRPS/PKS”. Furthemore, this peptide has shown a strong cytotoxic activity on various cancer cell lines. One of the problems of this lipopeptide, is the lack of information on its mechanism of action. To identify potential targets and also to study in structure activity relationships, confirmation of its structure is necessary. It is in this context that we undertook laxaphycine B's synthesis using SPPS. In a first step, the four non-ribosomal aminoacids have been synthesized. In a second step, our efforts have focused on the development of a synthesis strategy to obtain laxaphycine B. Lastly, we studied the laxaphycin B's secondary structure to understand its mechanism of action.
85

DEVELOPMENT AND EVALUATION OF NONRADIOACTIVE METHODS FOR MONITORING T LYMPHOCYTE RESPONSE TO EQUINE ARTERITIS VIRUS (EAV) IN HORSES

Kyomuhangi, Annet 01 January 2019 (has links)
Target cell lysis is the hallmark of immune effector responses of cytotoxic T lymphocytes (CTL), natural killer (NK) cells, and monocytes. The most commonly used assay to measure target cell lysis is the 51Cr release assay and is considered the ‘gold standard’. However, this assay has many disadvantages that limit its use by most laboratories. Thus, several alternative assays have been developed. Some of these alternative assays are more sensitive, easy to perform and do not use radioactive elements. In this study, four of these assays were evaluated for their ability to detect antigen- specific CTL responses in equine blood. Three long-term equine arteritis virus (EAV) carrier stallions, two vaccinated stallions and one naïve stallion were included in this study. Peripheral blood mononuclear cells (PBMCs) were isolated from whole blood collected of these stallions to be used as effector cells. The PBMCs were stimulated with EAV in vitro for 7-10 days to generate antigen-specific effector cells. The granzyme B assay, the Carboxyfluorescein succinimidyl ester (CFSE)/7-Aminoactinomycin D (7AAD) assay and the Lactate dehydrogenase (LDH) assay were performed using these effector cells and autologous equine dermal cells (isolated from each stallion) as target cells. The first two assays (i.e., granzyme B and CFSE/7AAD assays) were difficult to optimize for this study because they work well with non-adherent targets and require immediate flow cytometry analysis. The LDH assay, however detected CTL lysis in one of the two vaccinated stallions at day 99 post vaccination and no response was detected in PBMCs isolated from carrier stallions and control stallion. Based on these findings, the LDH assay is the most suitable assay since it works well with adherent target cells, it produces quantitative data, and is ideal for high-throughput screening.
86

Balancing Effector and Regulatory T Cell Responses in Cancer and Autoimmunity

Schreiber, Taylor Houghton 03 June 2010 (has links)
Activation of immunity to self-antigens is the goal in cancer immunotherapy, whereas blocking such responses is the goal in autoimmune disease. Thus, it is not surprising that investigation into cancer immunotherapy might also produce insights for the treatment of autoimmune disease. Heat shock protein, gp96, based therapies lead to the robust activation of CD8+ cytotoxic T cells that can slow tumor growth in 60-70% of mice, but only lead to the elimination of tumors in 30-40% of animals. The primary goal of the current studies was to understand why vaccination with a secreted gp96 vaccine was not efficacious in a larger proportion of animals, and identify combination therapies that enhanced the anti-tumor activity of gp96-Ig vaccination. It was found that in mice bearing established tumors, some mice responded well to vaccination with gp96-Ig, and that the induction of CD8+ T cells was found to correlate with tumor rejection; indicating that the proportion of mice that failed to reject tumors had established mechanisms of tumor-mediated suppression of anti-tumor immunity. The mechanism of this suppression was found to differ between various tumor models, so combination therapy sought to amplify CD8+ T cell responses directly, rather than by indirectly inhibiting suppressive factors induced by established tumors. It was found that antibody-based therapies leading to the stimulation of TNFRSF25, a powerful T cell co-stimulatory receptor, caused synergistic expansion of tumor-specific T cells when given in combination with gp96-Ig vaccination and led to enhanced rejection of multiple tumor types. Interestingly, TNFRSF25 agonistic antibodies were also found to directly stimulate the proliferation of natural CD4+FoxP3+ regulatory T cells. This activity was found to be beneficial in the prevention of allergic lung inflammation when administered prior to antigen challenge. These studies have therefore identified the conditions required for successful tumor elimination following gp96-Ig vaccination, and discovered that a TNFRSF25 agonistic antibody may be used to enhance anti-tumor immunity induced by gp96-Ig. These studies have also identified TNFRSF25 stimulation as the most powerful, and physiologically relevant, method to selectively induce Treg proliferation in vivo ever discovered, with important consequences for the treatment of autoimmune inflammation.
87

Methodological aspects within the FMCA-method : do incubation time and the amount of tumor cells influence the antitumoral effect?

Svensson, Johanna January 2008 (has links)
ABSTRACT Chemotherapy is a common method used for cancer treatment. Especially when it concerns cancers that have grown invasively it seems to be the only efficient treatment due to the substances ability to reach and affect almost the entire body. One major obstacle regarding chemotherapy is that the patients often develop resistance to the cytotoxic substances used. Fluorometric microculture cytotoxicity assay (FMCA) is a method developed to measure sensitivity of tumor cells to different cytotoxic substances in vitro. The assay is based on hydrolysis of fluorescein diacetate to fluorescein by cells with intact cell membranes after incubation with drugs for 72 hours. This study investigated the impact of two methodological factors that may cause errors in the achieved results; namely the possible occurrence of drug decay during incubation and the use of an inappropriate amount of cells. These factors were tested by exposing the cytotoxic drugs to pre-incubation in absence of tumor cells for different times and to use suspensions with different concentrations of cells. The results indicated occurrence of drug decay in 3 of the 18 substances tested and that the amount of cells affected the results for most of the drugs tested but to different extent.
88

Preclinical Characterization in vivo and in vitro of Novel Agents for Cancer Chemotherapy : Studies on Benomyl, Carbendazim, Cryptolepine and Acriflavine

Laryea, Daniel January 2010 (has links)
Preclinical methods for the identification and characterization of molecules for development into new cancer drugs were investigated. Based on repurposing, i.e. the exploration of currently prescribed drugs for new indications, and as a result of a new high throughput screening (HTS) approach, the benzimidazoles benomyl and carbendazim, the alkaloid cryptolepine and the acridine acriflavine were found interesting to characterize using these methods. In mice the benzimidazoles inhibited 3H-thymidine incorporation in tissues with high cell renewal, with benomyl being more active than carbendazim.  They were rapidly absorbed with highest amounts seen in the liver, kidneys and gastro-intestinal lumen as evidenced from distribution of 14C-labeled drugs. In human tumour cell lines, the benzimidazoles showed a similar activity pattern but benomyl was more potent. This was true also in tumour cells from patients but carbendazim was relatively more active against solid tumours. Analyses of drug activity cross-resistance patterns and of drug activity – gene expression correlations in a cell line panel suggested multiple mechanisms of action for the benzimidazoles. Cryptolepine was widely distributed to tissues in vivo in the mice. It was more potent than the benzimidazoles in tumour cells, with highest activity in haematological malignancies but some patient samples of breast, colon and non small-cell lung cancer were sensitive. Cross-resistance analysis indicated cryptolepine to be a topoisomerase II inhibitor whereas drug activity – gene expression correlations suggested additional mechanisms of action. HTS on 2 000 molecules in colon cancer cell lines and normal cells identified acriflavine as a hit molecule, subsequently shown to have unprecedented activity against colorectal cancer tumour cells in patient tumour samples. Connectivity map analysis, based on drug induced gene expression perturbation patterns in a tumour cell line, indicated acriflavine to be a topoisomerase inhibitor, subsequently confirmed in a plasmid relaxation assay. In conclusion, repurposing of drugs and HTS using stringent activity criteria followed by preclinical characterization might contribute to more efficient development of new cancer drugs.
89

Distribution and Chemical Diversity of Cyclotides from Violaceae : Impact of Structure on Cytotoxic Activity and Membrane Interactions

Burman, Robert January 2010 (has links)
During the last decade there has been increased interest in the cyclotide protein family, which consist of a circular chain of approximately 30 amino acids, including six cysteines that form three disulfide bonds, arranged in a cyclic cystine knot motif. This thesis gives new insights in cyclotide distribution and occurrence in the plant family Violaceae, structure-activity relationships for cytotoxic effects, membrane disruption and adsorption on lipid membranes, and evaluates toxicity and anti-tumor activity in vivo. A large-scale analysis was done on over 200 samples covering 17 of the 23 genera in Violaceae, and cyclotides were positively identified in almost 150 of approximately 900 known species. Conclusions are that the Violaceae is an extremely rich source of cyclotides, and that they are ubiquitous among all species in that plant family. After investigating the cyclotides' cytotoxicity it was evident that the effects were immediate and occurred at low micromolar concentrations. To understand the relationships between structure and activity, approximately 30 cyclotides and cyclotide derivates were assayed for cytotoxicity. Results showed that the overall charge is of minor influence on activity and revealed a strong correlation between an intact hydrophobic molecular surface and cytotoxic effect. The cytotoxic activity is mainly due to interactions between peptides and target membranes, illustrated by prototypic cyclotides' ability to induce liposome leakage and adsorb to lipid membranes. Cyclotides were strongly lytic against zwitterionic liposomes, less when cholesterol was included, while for anionic liposomes, activity depend on the net charge of cyclotide. A similar pattern was observed for the adsorption of the cyclotides to anionic bilayers, in which strong lytic activity was coupled with high adsorption. To further evaluate cyclotides cytotoxic effects, in vivo studies were conducted, both for acute toxicity and anti-tumor efficacy in mice. Two different methods were used: hollow fiber method and traditional xenografts, but no significant anti-tumor effects were detected. The results indicate that anti-tumor effects are minor or absent at tolerable doses and that cyclotides have a very abrupt in vivo toxicity profile, with lethality after single injection at 2.0 mg/kg.
90

Receptor-Mediated Antigen Delivery by &Alpha;<Sub>2</Sub>-Macroglobulin: Effect on Cytotoxic T Lymphocyte Immunity and Implications for Vaccine Development

Bowers, Edith Villette January 2009 (has links)
<p><p>The receptor-recognized form of &alpha;<sub>2</sub>-macroglobulin (&alpha;<sub>2</sub>M*) targets antigens (Ag) to professional Ag-presenting cells (APCs) for rapid internalization, processing, and presentation. When employed as an Ag delivery vehicle, &alpha;<sub>2</sub>M* amplifies major histocompatibility complex (MHC) class II presentation as demonstrated by increased antibody (Ab) titers. Recent evidence, however, suggests that &alpha;<sub>2</sub>M*-encapsulation may also enhance Ag-specific cytotoxic T lymphocyte (CTL) immunity. In these studies, we demonstrate that &alpha;<sub>2</sub>M*-delivered Ag (ovalbumin, OVA) enhances the production of specific <italic>in vitro</italic> and <italic>in vivo</italic> CTL responses. <br><p>Murine splenocytes expressing a transgenic T cell receptor (TCR) specific for CTL peptide OVA<sub>257-264</sub> (SIINFEKL) demonstrated up to 25-fold greater IFN-&gamma; and IL-2 secretion when treated <italic>in vitro</italic> with &alpha;<sub>2</sub>M*-OVA compared to soluble OVA. The frequency of IFN-&gamma; -producing cells was increased ~15-fold as measured by ELISPOT. Expansion of the OVA-specific CD8<super>+</super> T cells, as assayed by tetramer binding and [<super>3</super>H]thymidine incorporation, and cell-mediated cytotoxicity, as determined by a flow cytometric assay, were also significantly enhanced by &alpha;<sub>2</sub>M*-OVA. Furthermore, CTL responses were observed at Ag doses tenfold lower than those required with OVA alone. <br><p>We also observed enhanced humoral and CTL responses by naïve mice following intradermal immunization with &alpha;<sub>2</sub>M*-OVA. These &alpha;<sub>2</sub>M*-OVA-immunized mice displayed increased protection against a subcutaneously implanted OVA-expressing tumor, as demonstrated by delayed tumor growth and prolonged animal survival. The anti-tumor response observed with &alpha;<sub>2</sub>M*-mediated Ag delivery was comparable to that of an accepted vaccine adjuvant (CpG 1826) and appeared superior to a cell-based vaccine technique. <br><p>To further understand the mechanism underlying this enhanced CTL immunity, the subsets of professional APCs capable of cross-presenting &alpha;<sub>2</sub>M*-encapsulated Ag were investigated. Although both dendritic cells (DCs) and macrophages appear to stimulate some degree of cross-priming in response to &alpha;<sub>2</sub>M*-encapsulated Ag, CD8<super>+</super>CD4<super>-</super> and CD8<super>-</super>CD4<super>+</super> DCs appear to do so with the greatest efficiency. The implications of this finding to the ongoing debate regarding the relative contributions of APC subsets to Ag cross-presentation and the determinants of which cells cross-present with high efficiency are discussed. <br><p>These observations demonstrate that &alpha;<sub>2</sub>M*-mediated Ag delivery promotes cross-presentation resulting in enhanced Ag-specific CTL immunity. Considered in the context of previous work, these results support &alpha;<sub>2</sub>M* as an effective Ag delivery system that may be particularly useful for vaccines based on weakly immunogenic subunits or requiring dose sparing.</p> / Dissertation

Page generated in 0.0281 seconds